Charm Therapeutics

Charm Therapeutics company information, Employees & Contact Information

CHARM Therapeutics is discovering and developing small molecule medicines against difficult-to-drug targets with our proprietary 3D deep learning-enabled platform, DragonFold. Powered by the first high throughput protein-ligand co-folding algorithm and a world-class team of scientists and engineers, CHARM seeks to deliver innovative approaches to create life-changing therapies for patients.

Company Details

Employees
58
Founded
-
Address
London, Gb
Industry
Research Services
NAICS
Scientific Research and Development Services
Research and Development in the Physical, Engineering, and Life Sciences
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
HQ
London
Looking for a particular Charm Therapeutics employee's phone or email?

Charm Therapeutics Questions

News

CHARM Therapeutics Bolsters Leadership Team with Key Promotion and Strategic Appointment - Business Wire

CHARM Therapeutics Bolsters Leadership Team with Key Promotion and Strategic Appointment Business Wire

CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB) - GlobeNewswire

CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB) GlobeNewswire

CHARM Therapeutics raises $80 million in Series B financing to advance development of best-in-class menin inhibitor for AML - The Manila Times

CHARM Therapeutics raises $80 million in Series B financing to advance development of best-in-class menin inhibitor for AML The Manila Times

CHARM Therapeutics Receives Investment for Deep Learning-Enabled Drug Discovery Research from NVIDIA - Business Wire

CHARM Therapeutics Receives Investment for Deep Learning-Enabled Drug Discovery Research from NVIDIA Business Wire

CHARM Therapeutics launches with a $50 million Series A - GlobeNewswire

CHARM Therapeutics launches with a $50 million Series A GlobeNewswire

CHARM Therapeutics Announces Collaboration with Bristol Myers Squibb to Enable and Accelerate Small Molecule Drug Discovery Programs - Business Wire

CHARM Therapeutics Announces Collaboration with Bristol Myers Squibb to Enable and Accelerate Small Molecule Drug Discovery Programs Business Wire

Top Charm Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant